It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Multimodality treatment of unresectable hepatic metastases from pancreatic glucagonoma | Poggi | Rare Tumors
Login   |   Register
Cover Image

Multimodality treatment of unresectable hepatic metastases from pancreatic glucagonoma

Guido Poggi, Laura Villani, Giovanni Bernardo

Abstract


Glucagonomas are pancreatic islet cell tumors arising from the alpha cells which belong to neuroendocrine tumors. They frequently metastasize to the liver. We report the case of a 52- year old man with a pancreatic glucagonoma with synchronous multiple liver metastases treated by surgery, transarterial chemoembolization, percutaneous radiofrequency thermal ablation and long-acting octreotide. Our report confirms that a multimodal approach is very effective in patients with unresectable liver metastases from pancreatic endocrine tumors providing long-lasting palliation and probably prolonging survival.

Keywords


Neuroendocrine tumors; liver metastases; hepatic transarterial chemoembolization

Full Text:

PDF HTML


DOI: http://dx.doi.org/10.4081/rt.2009.e6
Submitted: 2009-06-12 17:51:49
Published: 2009-07-07 11:39:23
Search for citations in Google Scholar
Related articles: Google Scholar


 

FOOTER

Rare Tumors [ISSN 2036-3605, eISSN 2036-3613] is an Open Access, peer-reviewed journal published by PAGEPress, Pavia, Italy. All credits and honors to PKP for their OJS.

 

 

 

 
 
© PAGEPress 2008-2013     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185